Cullinan Oncology Completes $98.5 Million Series B Financing
Go back to Cullinan Oncology Completes $98.5 Million Series B Financing| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 55.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.60 | 52 Week High | $77.12 | |||
| Open | $55.60 | 52 Week Low | $49.03 | |||
| Day High | $55.60 | P/E | 36.10 | |||
| Day Low | $55.60 | EPS | $1.54 | |||
| Volume | 2,648 | |||||
| MACROGENICS (NASDAQ: MGNX) | Delayed: 3.87 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.87 | 52 Week High | $36.11 | |||
| Open | $3.87 | 52 Week Low | $14.84 | |||
| Day High | $3.87 | P/E | 9.92 | |||
| Day Low | $3.87 | EPS | $0.39 | |||
| Volume | 48 | |||||
